Gingival hyperplasia: Difference between revisions
(Created page with "==Background== *Gingival Hyperplasia/hypertrophy main causes are inflammatory, drug-induced, or systemic ==Clinical Features== *Swollen gums *Bright red or purple *+/- bleedi...") |
No edit summary |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
==Clinical Features== | ==Clinical Features== | ||
[[File:gingivitis.jpg|thumb|Inflammatory Gingival Hyperplasia]] | |||
[[File:gingival_hyperplasia.png|thumb|Gingival Hyperplasia from Diltiazem]] | |||
*Swollen gums | *Swollen gums | ||
*Bright red or purple | *Bright red or purple | ||
*+/- bleeding and easily bleed with probing | *+/- [[gingival bleeding|bleeding]] and easily bleed with probing | ||
*Poor oral hygiene | *Poor oral hygiene | ||
| Line 13: | Line 15: | ||
**Poor oral hygiene and plaque retention | **Poor oral hygiene and plaque retention | ||
**Restorative and Orthodontic Applicances | **Restorative and Orthodontic Applicances | ||
*Drug Induced hyperplasia | *Drug Induced hyperplasia<ref>Bharti V et al. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. Journal of Indian Society of Periodontology. 2013;17(2):182-187. doi:10.4103/0972-124X.113066.</ref> | ||
**Anti-convulsants (Phenytoin, | **Anti-convulsants ([[Phenytoin]], [[Valproate]], etc.) | ||
**Immunosuppressants (Cyclosporine, Tacrolimus, etc.) | **Immunosuppressants ([[Cyclosporine]], [[Tacrolimus]], etc.) | ||
**Calcium channel blockers (Nifedipine, Amlodipine, etc.) | **Calcium channel blockers ([[Nifedipine]], [[Amlodipine]], etc.) | ||
*Congenital Hyperplasia | *Congenital Hyperplasia | ||
*Systemic causes of Hyperplasia | *Systemic causes of Hyperplasia | ||
**Leukemia | **[[Leukemia]] | ||
**Granulomatous disease | **Granulomatous disease | ||
***Granulomatosis with | ***[[Granulomatosis with polyangiitis]] | ||
***Sarcoidosis | ***[[Sarcoidosis]] | ||
**Pyogenic granuloma | **Pyogenic granuloma | ||
**Pregnancy | **[[Pregnancy]] | ||
**Warts | **Warts | ||
**Lymphoproliferative disease | **Lymphoproliferative disease (e.g. [[leukemia]], [[lymphoma]]) | ||
**Paraneoplastic syndrome | **[[Paraneoplastic]] syndrome | ||
**Benign Neoplasms | **Benign Neoplasms | ||
***Papilloma, Fibroma, Giant Cell granuloma | ***Papilloma, Fibroma, Giant Cell granuloma | ||
*Periodontitis | *Periodontitis | ||
==Management== | ==Management== | ||
*Improve oral hygiene | *Improve oral hygiene<ref>Dahlen G et al. The effect of supragingival plaque control on the subgingival microbiota in subjects with periodontal disease. J Clin Periodontol. 1992;19:802–9.</ref> | ||
*Follow up with dentist, oral medicine, or periodontist | *Follow up with dentist, oral medicine, or periodontist | ||
*Chlorhexidine Gluconate 0.12% for inflammatory causes | *Chlorhexidine Gluconate 0.12% for inflammatory causes<ref> | ||
Pundir AJ et al. Treatment of drug-induced gingival overgrowth by full-mouth disinfection: A non-surgical approach. Journal of Indian Society of Periodontology. 2014;18(3):311-315. doi:10.4103/0972-124X.134567.</ref> | |||
*Stop offending drug | *Stop offending drug | ||
*Treat systemic problem | *Treat systemic problem | ||
| Line 44: | Line 44: | ||
==Disposition== | ==Disposition== | ||
*Treated outpatient | *Treated outpatient | ||
**Periodontal debridement, gingivectomy, laser surgery<ref>Mavrogiannis M et al. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol. 2006;33:677–82.</ref> | |||
==See Also== | ==See Also== | ||
[[Dental Problems]] | |||
==References== | |||
<references/> | |||
[[Category:ENT]] | |||
[[Category:Symptoms]] | |||
Latest revision as of 22:02, 2 December 2021
Background
- Gingival Hyperplasia/hypertrophy main causes are inflammatory, drug-induced, or systemic
Clinical Features
- Swollen gums
- Bright red or purple
- +/- bleeding and easily bleed with probing
- Poor oral hygiene
Differential Diagnosis
- Inflammatory hyperplasia
- Gingivitis
- Poor oral hygiene and plaque retention
- Restorative and Orthodontic Applicances
- Drug Induced hyperplasia[1]
- Anti-convulsants (Phenytoin, Valproate, etc.)
- Immunosuppressants (Cyclosporine, Tacrolimus, etc.)
- Calcium channel blockers (Nifedipine, Amlodipine, etc.)
- Congenital Hyperplasia
- Systemic causes of Hyperplasia
- Leukemia
- Granulomatous disease
- Pyogenic granuloma
- Pregnancy
- Warts
- Lymphoproliferative disease (e.g. leukemia, lymphoma)
- Paraneoplastic syndrome
- Benign Neoplasms
- Papilloma, Fibroma, Giant Cell granuloma
- Periodontitis
Management
- Improve oral hygiene[2]
- Follow up with dentist, oral medicine, or periodontist
- Chlorhexidine Gluconate 0.12% for inflammatory causes[3]
- Stop offending drug
- Treat systemic problem
Disposition
- Treated outpatient
- Periodontal debridement, gingivectomy, laser surgery[4]
See Also
References
- ↑ Bharti V et al. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. Journal of Indian Society of Periodontology. 2013;17(2):182-187. doi:10.4103/0972-124X.113066.
- ↑ Dahlen G et al. The effect of supragingival plaque control on the subgingival microbiota in subjects with periodontal disease. J Clin Periodontol. 1992;19:802–9.
- ↑ Pundir AJ et al. Treatment of drug-induced gingival overgrowth by full-mouth disinfection: A non-surgical approach. Journal of Indian Society of Periodontology. 2014;18(3):311-315. doi:10.4103/0972-124X.134567.
- ↑ Mavrogiannis M et al. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol. 2006;33:677–82.